agilon health, inc. — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 4/100
What the filing says
Timothy O'Rourke (CEO) and Jeffrey Schwaneke (CFO) issued routine Sarbanes-Oxley certifications for the 10-Q period ended June 30, 2026, dated August 5, 2026. Both officers certified that financial statements fairly present the company's financial condition and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, deficiencies, or fraud were disclosed.
Why this rating
Boilerplate SOX certification exhibits; routine periodic disclosure with no substance changes, control issues, or business events disclosed.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.